+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antibiotics Market Research Reports

From
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2024 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Antimicrobial Resistance (AMR) - Pipeline Insight, 2024 - Product Thumbnail Image

Antimicrobial Resistance (AMR) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Vancomycin resistant Enterococcal infections - Pipeline Insight, 2024 - Product Thumbnail Image

Vancomycin resistant Enterococcal infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cell Wall Synthesis Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cell Wall Synthesis Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 90 Pages
  • Global
From
Protein 50S ribosomal subunit inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Protein 50S ribosomal subunit inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Topoisomerase Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Topoisomerase Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Type II DNA topoisomerase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Type II DNA topoisomerase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 85 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Antibiotics market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of drugs used to treat bacterial infections. Antibiotics are used to treat a wide range of bacterial infections, from minor skin infections to life-threatening illnesses such as pneumonia and meningitis. Antibiotics are also used to prevent infections in people who are at risk of developing them, such as those undergoing surgery or chemotherapy. The Antibiotics market is highly competitive, with many large pharmaceutical companies competing for market share. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. These companies are constantly researching and developing new antibiotics to treat a variety of bacterial infections. Show Less Read more